ETC-216 is a synthetic variant of high-density lipoprotein (HDL) and one of several HDL targeted therapies the company is developing for patients with CHD.
-
ETC-216 is a synthetic variant of high-density lipoprotein (HDL) and one of... -
Contrast between a healthy and an atherosclerotic artery. (Source: ABPI) -
Single agent therapy. (Source: ABPI)
